-
-
BISMUTH SUBSALICYLATE (Generic for PEPTO-BISMOL)
- QTY 360
- 262MG/15ML
- Oral Suspension
- Near 77381
DIPHENHYDRAMINE (dye fen HYE dra meen) treats the symptoms of allergies and allergic reactions. It works by blocking histamine, a substance released by the body during an allergic reaction. It may also be used to prevent and treat motion sickness or the symptoms of Parkinson disease. It belongs to a group of medications called antihistamines.
Change Location
Set Price Drop Alert for:
BISMUTH SUBSALICYLATE (Generic for PEPTO-BISMOL)
- QTY 360
- 262MG/15ML
- Oral Suspension
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
BISMUTH SUBSALICYLATE (Generic for PEPTO-BISMOL)
- QTY 360
- 262MG/15ML
- Oral Suspension
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Medicine Chest
BISMUTH SUBSALICYLATE (Generic for PEPTO-BISMOL) Lifestyle Interactions
-
Bismuth Subsalicylate 525mg/30mL, Oral suspension
• Interaction: Alcohol• Severity: Major• Notes for Consumers: Do not drink alcohol while taking this medication. Drinking alcohol while taking this medication increases the risk of stomach bleeding. Contact your care team right away if you experience bloody or black, tar-like stools, vomiting blood or brown material that looks like coffee grounds.• Notes for Professionals: Concomitant ingestion of alcohol with salicylates, especially aspirin, ASA, increases the risk of developing gastric irritation and GI mucosal bleeding. Alcohol and salicylates are mucosal irritants and aspirin decreases platelet aggregation. Routine ingestion of alcohol and aspirin can cause significant GI bleeding, which may or may not be overt. Even occasional concomitant use of salicylates and alcohol should be avoided. Chronic ingestion of alcohol is often associated with hypoprothrombinemia and this condition increases the risk of salicylate-induced bleeding. Patients should be warned regarding the potential for increased risk of GI bleeding if alcohol-containing beverages are taken concurrently with salicylates.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
